Research Article

PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia

Table 2

Correlation and multiple regression analyses of the baseline parameters associated with serum irisin levels.

ParametersCorrelation Multiple regression
value value

Age (years)0.2150.085
BMI (kg/m2)0.3140.011
SBP (mmHg)0.1260.316
DBP (mmHg)−0.1070.395
FBG (mmol/L)0.3990.0015.615<0.001
TC (mmol/L)0.2560.040
HDL (mmol/L)0.2470.04719.483<0.001
LDL (mmol/L)0.1090.387
TG (mmol/L)0.2300.065
HbA1c (%)0.2390.055

BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; HbA1c, glycosylated hemoglobin. The following variables were included in the multiple stepwise regression analysis: age, sex, BMI, SBP, DBP, FBG, TC, HDL-C, LDL-C, TG, and HbA1c.